The introduction of high-purity products in Canada

G H Growe1, C Rivet1

  • 1Transfusion Service, Vancouver Hospital & Health Sciences Centre, Vancouver, British Columbia, Canada,Canadian Blood Agency, Ottawa, Ontario, Canada.

Insights

Canada transitioned to high-purity coagulation products in 1993, increasing costs but enabling practice monitoring. A collaborative working group effectively evaluated this product conversion and its impact.

Area of Science:

  • Hematology
  • Pharmacoeconomics
  • Public Health Policy

Background:

  • In October 1993, Canada adopted high-purity coagulation products (recombinant or purified factor concentrates) for managing coagulation deficiencies.
  • This shift led to a significant cost increase of approximately $30 million (40%) for the national inventory.

Purpose of the Study:

  • To monitor the impact of introducing new high-purity coagulation products.
  • To evaluate long-term outcomes including inhibitor formation, prophylaxis, immune status, and thrombosis incidence.
  • To develop clinical practice guidelines for Hemophilia and Von Willebrand's Disease.

Main Methods:

  • Establishment of a regular meeting forum for stakeholders (recipients, treaters, distributor, funders).
  • Implementation of a continuous usage monitoring system managed by the Canadian Blood Agency.
  • Inclusion of specific outcome studies by the Association of Hemophilia Clinic Directors of Canada.

Main Results:

  • Early identification of practice trends and rationales for unexpected product use.
  • Facilitation of planning and funding adjustments based on monitored data.
  • Effective evaluation of the conversion to new products and their national impact.

Conclusions:

  • The collaborative working group under the Canadian Blood Agency was effective in evaluating the product conversion.
  • The monitoring system provided early insights into practice trends and resource utilization.
  • This model can inform future endeavors in managing high-purity coagulation products.

Related Concept Videos

High-Performance Liquid Chromatography: Introduction01:11

High-Performance Liquid Chromatography: Introduction

High-performance liquid chromatography(HPLC), formerly referred to as High-pressure liquid chromatography, is a powerful technique used to separate, identify, and quantify components in complex mixtures. The term "high pressure" refers to using high pressure to push the liquid mobile phase through the tightly packed columns.
In HPLC, two phases play a critical role in the separation process:
4.0K
Detergent Purification of Membrane Proteins01:18

Detergent Purification of Membrane Proteins

Detergents are used to purify the integral proteins of the membrane. The hydrophobic portion of the detergent can replace membrane phospholipids while solubilizing the membrane proteins. When detergent monomers reach a specific concentration in a solution called critical micelle concentration (CMC), they form micelles. Above CMC, the concentration of the detergent monomers remains in equilibrium with the micelle. The number of detergent monomers present in the CMC varies for each detergent, and...
6.8K
Chromatography: Introduction01:10

Chromatography: Introduction

Chromatography is a technique used to separate compounds based on differences of partitioning between two phases, the stationary phase and the mobile phase.
The phase in which the compounds linger or on which the compounds adsorb is called the stationary phase, whereas the mobile phase is the solvent that carries the solutes to be analyzed. In traditional column chromatography, the mixture flows through the stationary phase, and the compounds partition between the stationary and mobile phases...
8.2K
Production of Pharmaceuticals01:30

Production of Pharmaceuticals

Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under...
9
Inductively Coupled Plasma–Mass Spectrometry (ICP–MS): Overview01:19

Inductively Coupled Plasma–Mass Spectrometry (ICP–MS): Overview

In inductively coupled plasma–mass spectrometry (ICP–MS), an inductively coupled plasma (ICP) torch is used as an atomizer and ionizer. Solid samples are dissolved and volatilized before being introduced into the high-temperature argon plasma, while solution samples are nebulized and passed through the high-temperature argon plasma. Plasma dissociates the analytes and ionizes their component atoms to form a mixture of positive ions and molecular species. The positive ions are then...
2.5K
Gas Chromatography–Mass Spectrometry (GC–MS)01:14

Gas Chromatography–Mass Spectrometry (GC–MS)

Gas chromatography–mass spectrometry (GC–MS) is the combination of analytical techniques of gas chromatography and mass spectrometry in a single instrument for analyzing a mixture of compounds. The gas chromatograph separates the compounds in the mixture, and the mass spectrometer analyzes each compound separately to determine the molecular masses and molecular structures.
A gas chromatograph consists of a long, narrow capillary column with a polysiloxane coating on the inner wall....
7.6K